首页> 外文期刊>European journal of clinical investigation >Paraoxonase and arylesterase activities in coronary artery disease.
【24h】

Paraoxonase and arylesterase activities in coronary artery disease.

机译:对氧磷酶和芳基酯酶活性在冠心病中的作用。

获取原文
获取原文并翻译 | 示例
       

摘要

Background Paraoxonase-1 is an enzyme with three activities which are inversely related to cardiovascular diseases. Accordingly, the aim of the study was to investigate the paraoxonase, arylesterase activities and oxidative/anti-oxidative status in coronary artery disease (CAD) and their correlation with the extent of CAD. Materials and methods Study populations of 193 patients with angiographically documented CAD, 83 patients with normal coronary angiograms (NCAD) and 55 healthy volunteers were included in the study. The patients with CAD were divided into three categories according to the number of diseased coronaries. Also, a Gensini score was calculated for each patient. Serum paraoxonase and arylesterase activities were measured spectrophotometrically. Oxidative and anti-oxidative status was evaluated by measuring serum lipid hydroperoxide (LOOH), total anti-oxidant status (TAS) and free sulfhydryl groups (-SH = total thiol). Lipid parameters were determined by routine laboratory methods. Results Serum paraoxonase and arylesterase activities, TAS and -SH levels were lower in the CAD group compared with the NCAD group and control group (P < 0.05, all). Serum LOOH levels of the CAD group were greater than those in both the control and NCAD groups (P < 0.05). The major decreases in paraoxonase, arylesterase activities, -SH and TAS levels and the major increase in LOOH levels were observed in the 3-vessels disease group. In multiple linear regression analysis, the Gensini score was independently correlated with paraoxonase activity (beta -0.469, P < 0.001), -SH levels (beta and history of diabetes. Conclusions Both paraoxonase activity and -SH levels are independently associated with the presence and extent of CAD. Reduced paraoxonase activity and -SH levels may play a role in the severity of coronary atherosclerosis.
机译:背景对氧磷酶-1是一种具有与心血管疾病成反比的三种活性的酶。因此,该研究的目的是研究冠状动脉疾病(CAD)中的对氧磷酶,芳基酯酶活性和氧化/抗氧化状态及其与CAD程度的相关性。材料和方法研究对象为193例具有血管造影记录的CAD患者,83例具有正常冠状动脉造影(NCAD)的患者和55名健康志愿者。冠心病患者根据患病冠状动脉的数量分为三类。同样,为每位患者计算Gensini分数。分光光度法测定血清对氧磷酶和芳基酯酶的活性。通过测量血清脂质过氧化氢(LOOH),总抗氧化剂状态(TAS)和游离巯基(-SH =总硫醇)来评估氧化和抗氧化状态。脂质参数通过常规实验室方法确定。结果与NCAD组和对照组相比,CAD组的血清对氧磷酶和芳基酯酶活性,TAS和-SH水平较低(P <0.05,全部)。 CAD组的血清LOOH水平高于对照组和NCAD组(P <0.05)。在三血管疾病组中观察到对氧磷酶,芳基酯酶活性,-SH和TAS水平的主要降低以及LOOH水平的主要升高。在多元线性回归分析中,Gensini评分与对氧磷酶活性(β-0.469,P <0.001),-SH水平(β和糖尿病史)独立相关。结论对氧磷酶活性和-SH水平均与存在和否相关。对氧磷酶活性和-SH水平降低可能在冠状动脉粥样硬化的严重程度中起作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号